Search results

  1. 1.
    0574949 - BFÚ 2024 RIV DE eng J - Journal Article
    Kahounová, Zuzana - Pícková, Markéta - Drápela, Stanislav - Bouchal, J. - Szczyrbova, E. - Navrátil, J. - Souček, Karel
    Circulating tumor cell-derived preclinical models: current status and future perspectives.
    Cell Death & Disease. Roč. 14, č. 8 (2023), č. článku 530. ISSN 2041-4889. E-ISSN 2041-4889
    R&D Projects: GA ČR(CZ) GA20-22984S; GA MZd(CZ) NU21-08-00023
    Institutional support: RVO:68081707
    Keywords : METASTATIC BREAST-CANCER * EX-VIVO CULTURE * PERIPHERAL-BLOOD
    OECD category: Cell biology
    Impact factor: 9, year: 2022
    Method of publishing: Open access
    https://www.nature.com/articles/s41419-023-06059-6
    Permanent Link: https://hdl.handle.net/11104/0350472
     
     
  2. 2.
    0574522 - BFÚ 2024 RIV US eng J - Journal Article
    Kvokačková, Barbora - Fedr, Radek - Kužílková, D. - Stuchlý, J. - Vávrová, A. - Navrátil, J. - Fabián, P. - Ondrussek, R. - Ovesná, P. - Remsik, J. - Bouchal, J. - Kalina, T. - Souček, Karel
    Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness.
    Molecular Oncology. Roč. 17, č. 6 (2023), s. 1024-1040. ISSN 1574-7891. E-ISSN 1878-0261
    R&D Projects: GA MZd(CZ) NV18-08-00245; GA MZd(CZ) NU21-08-00023; GA ČR(CZ) GA20-22984S; GA ČR(CZ) GA21-11585S
    Institutional support: RVO:68081707
    Keywords : mass cytometry * phenotypic plasticity * single-cell profiles * triple-negative breast cancer * tumor heterogeneity * unsupervised machine learning algorithm
    OECD category: Immunology
    Impact factor: 6.6, year: 2022
    Method of publishing: Open access
    https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13365
    Permanent Link: https://hdl.handle.net/11104/0350095
     
     
  3. 3.
    0571537 - BFÚ 2024 RIV CH eng J - Journal Article
    Ondrussek, R. - Kvokačková, Barbora - Krystofova, K. - Brychtová, Š. - Souček, Karel - Bouchal, J.
    Prognostic value and multifaceted roles of tetraspanin CD9 in cancer.
    Frontiers in Oncology. Roč. 13, MAR 17 2023 (2023), č. článku 1140738. ISSN 2234-943X. E-ISSN 2234-943X
    R&D Projects: GA MZd(CZ) NU21-08-00023; GA ČR(CZ) GA20-22984S
    Institutional support: RVO:68081707
    Keywords : cd9 * cancer * immunohistochemistry * prognosis * exosomes
    OECD category: Oncology
    Impact factor: 4.7, year: 2022
    Method of publishing: Open access
    https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1140738/full
    Permanent Link: https://hdl.handle.net/11104/0350454
     
     


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.